McGuire Capital Advisors’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$436K Buy
8,018
+6,017
+301% +$293K 0.24% 65
2026
Q1
$85.8K Buy
2,001
+1,479
+283% +$63.6K 0.05% 143
2025
Q4
$22.9K Buy
+522
New +$21.6K 0.01% 285

Other funds holding EXEL

McGuire Capital Advisors's EXEL Position: Q2 2026 in Review

McGuire Capital Advisors increased its Exelixis (EXEL) stake by 301% in Q2 2026, buying an estimated $293K and bringing the position to 8,018 shares worth $436K. The position accounts for 0.24% of the portfolio, ranked #65.

McGuire Capital Advisors first reported a position in EXEL in Q4 2025 and has held it in 3 quarters since. 754 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • McGuire Capital Advisors held 8,018 shares of Exelixis worth $436K as of Q2 2026.
  • McGuire Capital Advisors bought 6,017 Exelixis shares in Q2 2026, an estimated $293K.
  • Exelixis made up 0.24% of McGuire Capital Advisors's portfolio in Q2 2026, its #65 holding.
  • McGuire Capital Advisors first reported a position in Exelixis in Q4 2025 and has held it in 3 quarters since.
  • 754 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on McGuire Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.